Physician

Ron Kenneth Lord, M.D.

According to 2025 Medicare claims, Ron Lord, M.D. (NPI: 1790991107) practices ophthalmology in the St. George, UT market, with the plurality of this provider's patient population coming from Washington, UT. This provider's primary affiliated billing organization is RETINA ASSOCIATES OF SOUTHERN UTAH (NPI: 1326307083; TIN: 45-4843605) and primary practice location at 84790-7134. Lord is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Lord's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,520 traditional Medicare patients, billed 91,646 HCPCS/CPT codes, and received $5,282,780 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 917 prescription claims across 287 beneficiaries totaling $18,199 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 17 records totaling $379. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $904,556 to $5,282,780. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $13,034 and ending at $18,199. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.6M$5.3M2015 Medicare payment: $904,556 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,011,818 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,299,006 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,587,607 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,935,797 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,615,883 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,548,783 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,533,463 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,226,185 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,282,780 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156936,873$904,556
201689512,162$1,011,818
20171,01512,727$1,299,006
20181,02712,817$1,587,607
20191,18614,092$1,935,797
20201,18615,463$2,615,883
20211,22015,300$2,548,783
20221,31317,975$2,533,463
20231,44347,941$3,226,185
20241,52091,646$5,282,780

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$12K$23K2015 Drug cost: $13,034 (USD; Tot_Drug_Cst)2016 Drug cost: $21,583 (USD; Tot_Drug_Cst)2017 Drug cost: $21,940 (USD; Tot_Drug_Cst)2018 Drug cost: $21,690 (USD; Tot_Drug_Cst)2019 Drug cost: $23,061 (USD; Tot_Drug_Cst)2020 Drug cost: $21,790 (USD; Tot_Drug_Cst)2021 Drug cost: $16,558 (USD; Tot_Drug_Cst)2022 Drug cost: $15,547 (USD; Tot_Drug_Cst)2023 Drug cost: $19,685 (USD; Tot_Drug_Cst)2024 Drug cost: $18,199 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598322$13,034
2016153479$21,583
2017181506$21,940
2018186519$21,690
2019202614$23,061
2020169525$21,790
2021175532$16,558
2022187531$15,547
2023248697$19,685
2024287917$18,199

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye6283,386$94
92004New patient complete exam of visual system327327$88
92014Established patient complete exam of visual system1,0241,447$82
J9035Injection, bevacizumab, 10 mg3592,009$55
92134Imaging of retina1,4045,467$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate4249,408$12,532
OfloxacinOfloxacin1522,688$1,796
Timolol MaleateTimolol Maleate1314,414$1,034
LatanoprostLatanoprost512,450$674
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat432,550$597

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$379ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ron Kenneth Lord, M.D.?

Tedicare shows public-source Medicare data for Ron Kenneth Lord, M.D. (NPI 1790991107), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ron Kenneth Lord, M.D. have ACO affiliation data?

Ron Kenneth Lord, M.D. is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Ron Kenneth Lord, M.D.?

Ron Kenneth Lord, M.D. is linked to RETINA ASSOCIATES OF SOUTHERN UTAH (billing NPI 1326307083) in the available physician profile data.

Does Ron Kenneth Lord, M.D. have Open Payments data?

Ron Kenneth Lord, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.